IMR Press / EJGO / Volume 21 / Issue 3 / pii/2000153

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Distinguished Expert Series

Lyrnphadenectorny in ovarian cancer

Show Less
1 Department of Obstetrics and Gynaecology, Instituto Universitario Dexeus, Barcelona, Spain
2 Department of Radiology, Instituto Universitario Dexeus, Barcelona, Spain
Eur. J. Gynaecol. Oncol. 2000, 21(3), 215–222;
Published: 10 June 2000
Abstract

Current guidelines for the surgical staging of ovarian cancer include the removal of retroperitoneal lymph nodes (pelvic and aor­tic). In most centres this is achieved by means of laparotomy, but advanced laparoscopic techniques have also been performed and still further prospective controlled studies with long-term follow-up are necessary to validate the efficacy. Lymph node sampling, short of complete dissection, should be avoided because it may be insufficient to detect metastasis. In any case, laparoscopic lymphade­nectomy as well as open surgery, should be in the hands of properly trained subspecialists in gynaecologic oncology. Of 97 patients with ovarian carcinoma studied in our hospital, 68% were treated by means of complete staging laparotomy (FIGO). Lymphadenec­tomy was spared in 14 cases with stage I tumours (mainly serous) without changes in overall survival. In 15% metastases in pelvic lymph nodes were present. In the same proportion aortic lymph nodes were positive. In 5.5%, aortic metastases were present in the absence of pelvic involvement.

Keywords
Ovarian cancer
Treatment
Lymphadenectomy
Share
Back to top